Cellectis OverviewCellectis EBIT
EBIT (Earnings Before Interest and Taxes) analysis for CLLS.
Quarterly EBIT
-$27.10M
↓ 67.11% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$53.72M
↓ 8.86% YoY
Trailing 12 months ending Mar 31, 2026
Cellectis OverviewEBIT (Earnings Before Interest and Taxes) analysis for CLLS.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026